Tau is required for glial lipid droplet formation and resistance to neuronal oxidative stress
- 26 August 2024
- journal article
- research article
- Published by Springer Nature in Nature Neuroscience
- Vol. 27 (10) , 1918-1933
Abstract
The accumulation of reactive oxygen species (ROS) is a common feature of tauopathies, defined by Tau accumulations in neurons and glia. High ROS in neurons causes lipid production and the export of toxic peroxidated lipids (LPOs). Glia uptake these LPOs and incorporate them into lipid droplets (LDs) for storage and catabolism. We found that overexpressing Tau in glia disrupts LDs in flies and rat neuron–astrocyte co-cultures, sensitizing the glia to toxic, neuronal LPOs. Using a new fly tau loss-of-function allele and RNA-mediated interference, we found that endogenous Tau is required for glial LD formation and protection against neuronal LPOs. Similarly, endogenous Tau is required in rat astrocytes and human oligodendrocyte-like cells for LD formation and the breakdown of LPOs. Behaviorally, flies lacking glial Tau have decreased lifespans and motor defects that are rescuable by administering the antioxidant N-acetylcysteine amide. Overall, this work provides insights into the important role that Tau has in glia to mitigate ROS in the brain.Keywords
This publication has 104 references indexed in Scilit:
- TNPO2 variants associate with human developmental delays, neurologic deficits, and dysmorphic features and alter TNPO2 activity in DrosophilaThe American Journal of Human Genetics, 2021
- The potential role of glial cells in driving the prion-like transcellular propagation of tau in tauopathiesBrain, Behavior, & Immunity - Health, 2021
- Astrocytes in stress accumulate lipid dropletsGlia, 2021
- A Neuron‐Glia Co‐culture System for Studying Intercellular Lipid TransportCurrent Protocols in Cell Biology, 2019
- A Single-Cell Transcriptome Atlas of the Aging Drosophila BrainCell, 2018
- Glial Lipid Droplets and ROS Induced by Mitochondrial Defects Promote NeurodegenerationCell, 2015
- Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's diseaseBrain Research, 2011
- Soluble hyper-phosphorylated tau causes microtubule breakdown and functionally compromises normal tau in vivoActa Neuropathologica, 2010
- Tau (MAPT) mutation Arg406Trp presenting clinically with Alzheimer disease does not share a common founder in Western EuropeHuman Mutation, 2003
- über eigenartige Krankheitsfälle des späteren AltersZeitschrift für die gesamte Neurologie und Psychiatrie, 1911